Trial
NCT07146087
Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis
Early Phase ISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Biocells Medical
Collaborators
—
Condition
Multiple Sclerosis
Intervention
MSC-Derived Exosomes
Why stopped
Slow enrolment of participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-28